Ying Zou1,2, Meizhu Zheng3, Ziyu Qi1, Yu Guo4, Xiaodong Ji4, Lixiang Huang4, Yan Gong1,5, Xiudi Lu1,2, Guolin Ma6, Shuang Xia4. 1. Radiological Department, First Central Clinical College, Tianjin Medical University, Tianjin, China. 2. Radiological Department, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China. 3. Radiological Department, Third Central Hospital of Tianjin, Tianjin, China. 4. Department of Radiology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China. 5. Radiological Department, Tianjin Hospital of ITCWM Nankai Hospital, Tianjin, China. 6. Radiological Department, China-Japan Friendship Hospital, Beijing, China.
Abstract
BACKGROUND: Dual-energy computed tomography (DECT) has been widely applied to detect lymph node (LN) and lymph node metastasis (LNM) in various cancers, including papillary thyroid carcinoma (PTC). This study aimed to quantitatively evaluate metastatic cervical lymph nodes (LNs) <0.5 cm in patients with PTC using DECT, which has not been done in previous studies. METHODS: Preoperative DECT data of patients with pathologically confirmed PTC were retrospectively collected and analyzed between May 2016 and June 2018. A total of 359 LNs from 52 patients were included. Diameter, iodine concentration (IC), normalized iodine concentration (NIC), and the slope of the energy spectrum curve (λHU) of LNs in the arterial and the venous phases were compared between metastatic and non-metastatic LNs. The optimal parameters were obtained from the receiver operating characteristic (ROC) curves. The generalized estimation equation (GEE) model was used to evaluate independent diagnostic factors for LNM. RESULTS: A total of 139 metastatic and 220 non-metastatic LNs were analyzed. There were statistical differences of quantitative parameters between the two groups (P value 0.000-0.007). The optimal parameter for diagnosing LNM was IC in the arterial phase, and its area under the curve (AUC), sensitivity, and specificity were 0.775, 71.9%, and 73.6%, respectively. When the three parameters of diameter, IC in the arterial phase, and NIC in the venous phase were combined, the prediction efficiency was better, and the AUC was 0.819. The GEE results showed that LNs located in level VIa [odds ratio (OR) 2.030, 95% confidence interval (CI): 1.134-3.634, P=0.017], VIb (OR 2.836, 95% CI: 1.597-5.038, P=0.000), diameter (OR 2.023, 95% CI: 1.158-3.532, P=0.013), IC in the arterial phase (OR 4.444, 95% CI: 2.808-7.035, P=0.000), and IC in the venous phase (OR 5.387, 95% CI: 3.449-8.413, P=0.000) were independent risk factors for LNM in patients with PTC. CONCLUSIONS: DECT had good diagnostic performance in the differentiation of cervical metastatic LNs <0.5 cm in patients with PTC. 2021 Quantitative Imaging in Medicine and Surgery. All rights reserved.
BACKGROUND: Dual-energy computed tomography (DECT) has been widely applied to detect lymph node (LN) and lymph node metastasis (LNM) in various cancers, including papillary thyroid carcinoma (PTC). This study aimed to quantitatively evaluate metastatic cervical lymph nodes (LNs) <0.5 cm in patients with PTC using DECT, which has not been done in previous studies. METHODS: Preoperative DECT data of patients with pathologically confirmed PTC were retrospectively collected and analyzed between May 2016 and June 2018. A total of 359 LNs from 52 patients were included. Diameter, iodine concentration (IC), normalized iodine concentration (NIC), and the slope of the energy spectrum curve (λHU) of LNs in the arterial and the venous phases were compared between metastatic and non-metastatic LNs. The optimal parameters were obtained from the receiver operating characteristic (ROC) curves. The generalized estimation equation (GEE) model was used to evaluate independent diagnostic factors for LNM. RESULTS: A total of 139 metastatic and 220 non-metastatic LNs were analyzed. There were statistical differences of quantitative parameters between the two groups (P value 0.000-0.007). The optimal parameter for diagnosing LNM was IC in the arterial phase, and its area under the curve (AUC), sensitivity, and specificity were 0.775, 71.9%, and 73.6%, respectively. When the three parameters of diameter, IC in the arterial phase, and NIC in the venous phase were combined, the prediction efficiency was better, and the AUC was 0.819. The GEE results showed that LNs located in level VIa [odds ratio (OR) 2.030, 95% confidence interval (CI): 1.134-3.634, P=0.017], VIb (OR 2.836, 95% CI: 1.597-5.038, P=0.000), diameter (OR 2.023, 95% CI: 1.158-3.532, P=0.013), IC in the arterial phase (OR 4.444, 95% CI: 2.808-7.035, P=0.000), and IC in the venous phase (OR 5.387, 95% CI: 3.449-8.413, P=0.000) were independent risk factors for LNM in patients with PTC. CONCLUSIONS: DECT had good diagnostic performance in the differentiation of cervical metastatic LNs <0.5 cm in patients with PTC. 2021 Quantitative Imaging in Medicine and Surgery. All rights reserved.
Authors: Mamoona T Khokhar; Kristopher M Day; Rohit B Sangal; Nigar N Ahmedli; Latha R Pisharodi; Michael D Beland; Jack M Monchik Journal: Thyroid Date: 2015-11-20 Impact factor: 6.568
Authors: Michael W Yeh; Andrew J Bauer; Victor A Bernet; Robert L Ferris; Laurie A Loevner; Susan J Mandel; Lisa A Orloff; Gregory W Randolph; David L Steward Journal: Thyroid Date: 2015-01 Impact factor: 6.568
Authors: Robert I Haddad; Christian Nasr; Lindsay Bischoff; Naifa Lamki Busaidy; David Byrd; Glenda Callender; Paxton Dickson; Quan-Yang Duh; Hormoz Ehya; Whitney Goldner; Megan Haymart; Carl Hoh; Jason P Hunt; Andrei Iagaru; Fouad Kandeel; Peter Kopp; Dominick M Lamonica; Bryan McIver; Christopher D Raeburn; John A Ridge; Matthew D Ringel; Randall P Scheri; Jatin P Shah; Rebecca Sippel; Robert C Smallridge; Cord Sturgeon; Thomas N Wang; Lori J Wirth; Richard J Wong; Alyse Johnson-Chilla; Karin G Hoffmann; Lisa A Gurski Journal: J Natl Compr Canc Netw Date: 2018-12 Impact factor: 11.908
Authors: J E Park; J H Lee; K H Ryu; H S Park; M S Chung; H W Kim; Y J Choi; J H Baek Journal: AJNR Am J Neuroradiol Date: 2017-01-26 Impact factor: 3.825